Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | D(3) dopamine receptor | ||
Ligand | BDBM476859 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
Ki | 0.085±n/a nM | ||
Citation | Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent US10870660 Publication Date 12/22/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
D(3) dopamine receptor | |||
Name: | D(3) dopamine receptor | ||
Synonyms: | DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3 | ||
Type: | n/a | ||
Mol. Mass.: | 44243.43 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM476859 | |||
n/a | |||
Name | BDBM476859 | ||
Synonyms: | US10870660, Compound II-005 | US11345716, Compound II-005 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H34F2N4O2S | ||
Mol. Mass. | 492.625 | ||
SMILES | Cc1ncc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OCC(F)F)nc4CC3)CC2)s1 |r,wU:12.12,wD:9.8,(13.07,1.84,;11.53,1.84,;10.63,.6,;9.16,1.07,;9.16,2.61,;7.83,3.38,;6.5,2.61,;6.5,1.07,;5.16,3.38,;3.83,2.61,;2.5,3.38,;1.16,2.61,;1.16,1.07,;-.17,.3,;-1.5,1.07,;-2.84,.3,;-2.72,-1.23,;-3.85,-2.28,;-5.37,-2.05,;-6.14,-3.38,;-7.68,-3.38,;-8.45,-2.05,;-9.99,-2.05,;-10.76,-.72,;-12.3,-.72,;-13.07,-2.05,;-13.07,.62,;-7.68,-.72,;-6.14,-.72,;-5.58,.72,;-4.11,1.17,;2.5,.3,;3.83,1.07,;10.63,3.09,)| | ||
Structure |